Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study

OBJECTIVE: To evaluate golimumab's effect on MRI-detected spinal inflammation in ankylosing spondylitis (AS). METHODS: Patients were randomly assigned to subcutaneous injections of placebo (n=78), golimumab 50 mg (n=138), or golimumab 100 mg (n=140) every 4 weeks. An MRI substudy comprising 98...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Braun, Jürgen, Baraliakos, Xenofon, Hermann, Kay-Geert A, van der Heijde, Désirée, Inman, Robert D, Deodhar, Atul A, Baratelle, Anna, Xu, Stephen, Xu, Weichun, Hsu, Benjamin
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2011
Assuntos:
Clinical and Epidemiological Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3371220/
https://ncbi.nlm.nih.gov/pubmed/22128083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2011-200308
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados